Sucrose

Sucrose

SCHEMBL19924992

OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.[CaH2].[MgH2]

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 1/20 0.78
CCNB1 P14635 1/20 0.78
CA2 P00918 1/20 0.53
CA9 Q16790 1/20 0.53
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
LDHA P00338 1/20 0.43
TYR P14679 1/20 0.41
EPHX2 P34913 1/20 0.40
ADORA1 P30542 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
POLB P06746 1/20 0.38
PTPN1 P18031 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sucrose SCHEMBL6364959 0.98 CDK1 (0.80) CDK1CCNB1CA2CA9MEN1
Sucrose SCHEMBL12095133 0.98 CDK1 (0.80) CDK1CCNB1CA2CA9MEN1
Sucrose SCHEMBL3750332 0.98 CDK1 (0.80) CDK1CCNB1CA2CA9MEN1
Sucrose SCHEMBL6662708 0.98 CDK1 (0.80) CDK1CCNB1CA2CA9MEN1
Sucrose SCHEMBL28293033 0.97 CDK1 (0.78) CDK1CCNB1CA2CA9MEN1
Sucrose SCHEMBL23549940 0.97 CDK1 (0.82) CDK1CCNB1CA2CA9MEN1
Sucrose SCHEMBL25403460 0.97 CDK1 (0.82) CDK1CCNB1CA2CA9MEN1
Sucrose SCHEMBL24274201 0.97 CDK1 (0.82) CDK1CCNB1CA2CA9MEN1
Sucrose SCHEMBL25403456 0.97 CDK1 (0.82) CDK1CCNB1CA2CA9MEN1
Sucrose SCHEMBL21907913 0.97 CDK1 (0.82) CDK1CCNB1CA2CA9MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3506936-A1 COMPOSITIONS GlaxoSmithKline Biologicals S.A. (BE) 2019-07-10 EP disclosed
WO-2018041891-A1 COMPOSITIONS GLAXOSMITHKLINE BIOLOGICALS SA (BE) 2018-03-08 WO disclosed